Valuation RAMM Pharma Corp.

Stocks

Market Closed - Canadian Securities Exchange Other stock markets 13:48:30 2026-07-03 EDT			5-day change	1st Jan Change
0.0100 ^CAD	0.00%		-33.33%	-83.33%

06-30	RAMM Pharma Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2026	CI
04-02	RAMM Pharma Corp. Reports Earnings Results for the First Quarter Ended January 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: October	2020	2021	2022	2023	2024	2025
Market Cap ¹	54.85	57.4	24.48	5.969	1.194	1.791
Change	-	4.66%	-57.35%	-75.61%	-80%	50%
Enterprise Value (EV) ¹	26.94	40.28	15.39	1.258	0.5682	1.067
Change	-	49.51%	-61.79%	-91.83%	-54.83%	87.86%
P/E	-7.44x	-7.1x	-1.17x	-0.78x	-0.07x	-0.2x
PBR	1.53x	1.02x	0.69x	0.2x	0.09x	0.31x
PEG	-	0.6x	-0x	0x	-0x	0x
Capitalization / Revenue	10.1x	13.9x	6.28x	1.18x	0.27x	0.53x
EV / Revenue	4.95x	9.79x	3.95x	0.25x	0.13x	0.32x
EV / EBITDA	-3.72x	-6.71x	-2.2x	-0.21x	-0.07x	-0.27x
EV / EBIT	-3.56x	-6.06x	-1.94x	-0.18x	-0.06x	-0.24x
EV / FCF	-14.3x	-8.01x	-4.06x	-0.54x	-0.2x	1.04x
FCF Yield	-6.98%	-12.5%	-24.7%	-184%	-504%	96.2%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.0739	-0.0655	-0.1707	-0.0638	-0.1382	-0.0746
Distribution rate	-	-	-	-	-	-
Net sales ¹	5.445	4.116	3.897	5.065	4.342	3.361
EBITDA ¹	-7.235	-6.007	-7.003	-6.037	-7.967	-3.929
EBIT ¹	-7.576	-6.642	-7.937	-7.086	-8.938	-4.531
Net income ¹	-7.431	-7.107	-20.96	-7.721	-16.5	-8.91
Net Debt ¹	-27.91	-17.12	-9.09	-4.712	-0.6257	-0.7235
Reference price ²	0.5500	0.4650	0.2000	0.0500	0.0100	0.0150
Nbr of stocks (in thousands)	99,723	123,449	122,400	119,389	119,389	119,389
Announcement Date	3/1/21	3/22/22	2/28/23	2/29/24	3/4/25	3/5/26

¹CAD in Million²CAD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
RAMM PHARMA CORP.	-	-	-	-	841K
ELI LILLY AND COMPANY	35.49x	12.89x	26.26x	0.56%	1,082B
JOHNSON & JOHNSON	28.11x	6.46x	17.57x	2.03%	633B
ABBVIE INC.	32.2x	7.69x	15.73x	2.65%	461B
ROCHE HOLDING AG	18.15x	4.51x	11.08x	2.94%	338B
ASTRAZENECA PLC	24.06x	5.03x	14.1x	1.73%	299B
NOVARTIS AG	22.19x	5.69x	13.74x	2.76%	291B
NOVO NORDISK A/S	14.43x	5.37x	11.03x	3.47%	222B
AMGEN INC.	24.39x	6.45x	11.36x	2.7%	202B
GILEAD SCIENCES, INC.	-46.87x	5.66x	31.47x	2.47%	163B
Average	16.90x	6.64x	16.92x	2.37%	369.24B
Weighted average by Cap.	24.74x	8.04x	18.59x	1.94%